chitosan has been researched along with buspirone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, SA; Patil, KS; Yeole, PG | 1 |
| Aiedeh, KM; Alkhalidi, B; Alkhatib, HS; Bustanji, Y; Hamed, S; Mohammad, MK; Najjar, S | 1 |
| Gaikwad, R; Khan, S; Patil, K; Yeole, P | 1 |
| Bshara, H; El-Shamy, Ael-H; Mansour, S; Osman, R | 1 |
| ElMeshad, AN; Fares, AR; Kassem, MA | 1 |
| Ali, J; Baboota, S; Bari, NK; Fazil, M; Gaba, B; Haider, MR; Hassan, MQ; Narang, JK | 1 |
6 other study(ies) available for chitosan and buspirone
| Article | Year |
|---|---|
Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies.
Topics: Adhesives; Administration, Intranasal; Animals; Anti-Anxiety Agents; Benzalkonium Compounds; Buspirone; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Female; Fibroblasts; Half-Life; Male; Mice; Nasal Mucosa; Permeability; Preservatives, Pharmaceutical; Rats; Swine | 2008 |
Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release.
Topics: Buspirone; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Hypromellose Derivatives; Kinetics; Methylcellulose; Osmolar Concentration; Sodium Chloride; Solubility; Spectrophotometry, Infrared; Tablets; Technology, Pharmaceutical | 2008 |
Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adhesives; Administration, Intranasal; Animals; Anti-Anxiety Agents; beta-Cyclodextrins; Biological Availability; Biological Transport; Brain; Buspirone; Chitosan; Drug Carriers; Drug Compounding; Injections, Intravenous; Male; Nasal Mucosa; Rats; Rats, Wistar; Solutions | 2009 |
Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Intranasal; Animals; Anti-Anxiety Agents; Area Under Curve; beta-Cyclodextrins; Biological Availability; Brain; Buspirone; Chitosan; Emulsions; Male; Nasal Mucosa; Rats; Rats, Wistar; Tissue Distribution | 2014 |
Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluation.
Topics: Animals; Biological Availability; Buspirone; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Freeze Drying; Microscopy, Electron, Scanning; Mouth Mucosa; Porifera | 2015 |
Brain delivery of buspirone hydrochloride chitosan nanoparticles for the treatment of general anxiety disorder.
Topics: Administration, Intranasal; Animals; Anti-Anxiety Agents; Anxiety Disorders; Biological Availability; Brain; Buspirone; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Liberation; Maze Learning; Molecular Structure; Nanoparticles; Particle Size; Permeability; Rats; Serotonin Receptor Agonists; Spectroscopy, Fourier Transform Infrared; Swine; X-Ray Diffraction | 2015 |